MYLAN, LDA; LABESFAL, Laboratorio Almiro S.A.; Generis Farmaceutica, S.A.; FARMOZ; LABORATORIO MEDINFAR - PRODUTOS FARMACEUTICOS, SA secures contract for 41/114/2026 Medicines For The Central Nervous System

Portugal, Feb. 6 -- Portugal based MYLAN, LDA; LABESFAL, Laboratorio Almiro S.A.; Generis Farmaceutica, S.A.; FARMOZ; LABORATORIO MEDINFAR - PRODUTOS FARMACEUTICOS, SA has secured contract from Unidade Local De Saude Do Algarve, E.P.E for 41/114/2026 Medicines For The Central Nervous System. The value of the contract is worth 1175568 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....